Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase.

Daniel Q Huang,Andrew Tran,Ming-Lun Yeh,Satoshi Yasuda,Pei-Chien Tsai,Chung-Feng Huang,Chia Yen Dai,Eiichi Ogawa,Masatoshi Ishigami,Takanori Ito,Ritsuzo Kozuka,Masaru Enomoto,Takanori Suzuki,Yoko Yoshimaru,Carmen Monica Preda,Raluca Ioana Marin,Irina Sandra,Sally Tran,Sabrina Xz Quek,Htet Htet Toe Wai Khine,Norio Itokawa,Masanori Atsukawa,Haruki Uojima,Tsunamasa Watanabe,Hirokazu Takahashi,Kaori Inoue,Mayumi Maeda,Joseph K Hoang,Lindsey Trinh,Scott Barnett,Ramsey Cheung,Seng Gee Lim,Huy N Trinh,Wan-Long Chuang,Yasuhito Tanaka,Hidenori Toyoda,Ming-Lung Yu,Mindie H Nguyen

Hepatology (Baltimore, Md.)（2023）

Cited 0|Views9
No score
Abstract
Antiviral therapy reduces HCC risk by 70% among indeterminate phase CHB patients. These data have important implications for the potential expansion of CHB treatment criteria.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined